Kazempour-Ardebili Sara, Lecamwasam Varunika L, Dassanyake Thushara, Frankel Andrew H, Tam Frederick W K, Dornhorst Anne, Frost Gary, Turner Jeremy J O
Department of Investigative Medicine, Imperial College London, Hammersmith Campus, London, UK.
Diabetes Care. 2009 Jul;32(7):1137-42. doi: 10.2337/dc08-1688. Epub 2009 Feb 5.
Optimizing glycemic control in diabetic patients undergoing maintenance hemodialysis requires accurate assessment. We hypothesize that 1) 48-h continuous glucose monitoring (CGM) provides additional, clinically relevant, information to that provided by the A1C measurement and 2) glycemic profiles differ significantly between day on and day off dialysis.
With the use of GlucoDay S, 48-h CGM was performed in 19 type 2 diabetic subjects undergoing hemodialysis to capture consecutive 24-h periods on and off dialysis. Energy intake was calculated using food diaries. A1C was assayed by a high-performance liquid chromatography method.
CGM data were available for 17 subjects (13 male) with a mean (range) age of 61.5 years (42-79 years) and diabetes duration of 18.8 years (4-30 years). The 24-h CGM area under the glucose curve and 24-h mean glucose values were significantly higher during the day off dialysis than on dialysis (5,932.1 +/- 2,673.6 vs. 4,694 +/- 1,988.0 mmol x 3 min(-1) x l(-1), P = 0.022, and 12.6 +/- 5.6 vs. 9.8 +/- 3.8 mmol/l, P = 0.013, respectively), independent of energy intake. Asymptomatic hypoglycemia occurred in 4 subjects, 3 within 24 h of dialysis, and the glucose nadir in 14 subjects occurred within 24 h of dialysis.
Glucose values are significantly lower on dialysis days than on nondialysis days despite similar energy intake. The risk of asymptomatic hypoglycemia was highest within 24 h of dialysis. Physicians caring for patients undergoing hemodialysis need to be aware of this phenomenon and consider enhanced glycemic monitoring after a hemodialysis session. CGM provides glycemic information in addition to A1C, which is potentially relevant to clinical management.
对接受维持性血液透析的糖尿病患者进行血糖控制优化需要准确评估。我们假设:1)48小时连续血糖监测(CGM)能提供超出糖化血红蛋白(A1C)测量所提供的、具有临床相关性的额外信息;2)透析日与非透析日的血糖谱存在显著差异。
使用GlucoDay S对19例接受血液透析的2型糖尿病患者进行48小时CGM,以获取透析日和非透析日连续的24小时时间段的数据。通过食物日记计算能量摄入。采用高效液相色谱法检测A1C。
17例受试者(13例男性)的CGM数据可用,平均(范围)年龄为61.5岁(42 - 79岁),糖尿病病程为18.8年(4 - 30年)。非透析日的24小时CGM葡萄糖曲线下面积和24小时平均血糖值显著高于透析日(分别为5932.1±2673.6与4694±1988.0 mmol·3 min⁻¹·l⁻¹,P = 0.022;以及12.6±5.6与9.8±3.8 mmol/L,P = 0.013),与能量摄入无关。4例受试者发生无症状低血糖,3例在透析后24小时内发生,14例受试者的血糖最低点出现在透析后24小时内。
尽管能量摄入相似,但透析日的血糖值显著低于非透析日。无症状低血糖风险在透析后24小时内最高。照顾接受血液透析患者的医生需要意识到这一现象,并考虑在血液透析 session 后加强血糖监测。CGM除了提供A1C外,还能提供与临床管理潜在相关的血糖信息。